Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Aug;26(2):160–163. doi: 10.1128/aac.26.2.160

Furazolidone versus ampicillin in the treatment of traveler's diarrhea.

H L DuPont, C D Ericsson, E Galindo, L V Wood, D Morgan, J A Bitsura, J G Mendiola
PMCID: PMC284111  PMID: 6385838

Abstract

Ninety-four U.S. students who acquired diarrhea in Mexico were treated with furazolidone (47 subjects) or ampicillin (47 subjects) on a double-blind random basis. Of 47 students, 26 (55%) who received furazolidone (100 mg four times daily for 5 days) recovered from illness within 48 h after initiation of therapy, in contrast to 15 of 47 (32%) who received ampicillin (500 mg four times daily for 5 days) (P less than 0.05). Altogether, 74% of students treated with furazolidone and 49% of those receiving ampicillin were well within 72 h (P less than 0.05). When furazolidone was compared with ampicillin, clinical illness was shortened on the average from 65 to 61 h for enterotoxigenic Escherichia coli diarrhea, from 83 to 58 h for shigellosis, from 82 to 51 h for diarrhea unassociated with a detectable agent, and from 72 to 57 h for all cases irrespective of etiology. Although not dramatically effective in the current trial, the broad spectrum of activity of furazolidone is of interest. Because of in vitro activity against Campylobacter strains and known effectiveness in treating giardiasis, furazolidone should be considered in therapy for diarrhea of unknown etiology in certain settings when laboratory processing of stools for etiological agent is not feasible.

Full text

PDF
160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassily S., Farid Z., Mikhail J. W., Kent D. C., Lehman J. S., Jr The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone. J Trop Med Hyg. 1970 Jan;73(1):15–18. [PubMed] [Google Scholar]
  2. Carlson J. R., Thornton S. A., DuPont H. L., West A. H., Mathewson J. J. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother. 1983 Oct;24(4):509–513. doi: 10.1128/aac.24.4.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chaudhuri R. N., Neogy K. N., Sanyal S. N., Gupta R. K., Manji P. Furazolidone in the treatment of cholera. Lancet. 1968 Feb 17;1(7538):332–333. doi: 10.1016/s0140-6736(68)90796-4. [DOI] [PubMed] [Google Scholar]
  4. Craft J. C., Murphy T., Nelson J. D. Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children. Am J Dis Child. 1981 Feb;135(2):164–166. doi: 10.1001/archpedi.1981.02130260056016. [DOI] [PubMed] [Google Scholar]
  5. DuPont H. L., Olarte J., Evans D. G., Pickering L. K., Galindo E., Evans D. J. Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med. 1976 Dec 30;295(27):1520–1521. doi: 10.1056/NEJM197612302952707. [DOI] [PubMed] [Google Scholar]
  6. DuPont H. L., Reves R. R., Galindo E., Sullivan P. S., Wood L. V., Mendiola J. G. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982 Sep 30;307(14):841–844. doi: 10.1056/NEJM198209303071401. [DOI] [PubMed] [Google Scholar]
  7. Dupont H. L., Ericsson C. D., Galindo E., Dupont M. W., Mendiola Gomez J. Antimicrobial therapy of travellers' diarrhoea. Scand J Gastroenterol Suppl. 1983;84:99–105. [PubMed] [Google Scholar]
  8. Ericsson C. D., DuPont H. L., Sullivan P., Galindo E., Evans D. G., Evans D. J., Jr Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Ann Intern Med. 1983 Jan;98(1):20–25. doi: 10.7326/0003-4819-98-1-20. [DOI] [PubMed] [Google Scholar]
  9. Fish C. H., Jones G. Furazolidone in the treatment of institutional shigellosis. Am J Ment Defic. 1968 Sep;73(2):214–217. [PubMed] [Google Scholar]
  10. Gutiérrez G., Serafín F., Sánchez R., Muñoz O., Kumate J. Evaluación de cuatro antimicrobianos en el tratamiento de tifoidea por Salmonella typhi resistente a cloranfenicol. Bol Med Hosp Infant Mex. 1974 Jul-Aug;31(4):597–606. [PubMed] [Google Scholar]
  11. Haltalin K. C., Nelson J. D. Failure of furazolidone therapy in shigellosis. Am J Dis Child. 1972 Jan;123(1):40–44. doi: 10.1001/archpedi.1972.02110070090011. [DOI] [PubMed] [Google Scholar]
  12. Kamat S. A. Furazolidone in treatment of salmonellosis. JAMA. 1968 Dec 16;206(12):2745–2745. [PubMed] [Google Scholar]
  13. Karchmer A. W., Curlin G. T., Huq M. I., Hirschhorn N. Furazolidone in paediatric cholera. Bull World Health Organ. 1970;43(3):373–378. [PMC free article] [PubMed] [Google Scholar]
  14. Levi G. C., de Avila C. A., Amato Neto V. Efficacy of various drugs for treatment of giardiasis. A comparative study. Am J Trop Med Hyg. 1977 May;26(3):564–565. doi: 10.4269/ajtmh.1977.26.564. [DOI] [PubMed] [Google Scholar]
  15. Lexomboon U., Mansuwan P., Duangmani C., Benjadol P., M'cMinn M. T. Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children. Br Med J. 1972 Jul 1;3(5817):23–26. doi: 10.1136/bmj.3.5817.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mathewson J. J., DuPont H. L., Morgan D. R., Thornton S. A., Ericsson C. D. Enteroadherent Escherichia coli associated with travellers' diarrhoea. Lancet. 1983 May 7;1(8332):1048–1048. doi: 10.1016/s0140-6736(83)92675-2. [DOI] [PubMed] [Google Scholar]
  17. Merson M. H., Morris G. K., Sack D. A., Wells J. G., Feeley J. C., Sack R. B., Creech W. B., Kapikian A. Z., Gangarosa E. J. Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med. 1976 Jun 10;294(24):1299–1305. doi: 10.1056/NEJM197606102942401. [DOI] [PubMed] [Google Scholar]
  18. Murphy T. V., Nelson J. D. Five v ten days' therapy with furazolidone for giardiasis. Am J Dis Child. 1983 Mar;137(3):267–270. doi: 10.1001/archpedi.1983.02140290053014. [DOI] [PubMed] [Google Scholar]
  19. Wolfe M. S. Giardiasis. JAMA. 1975 Sep 29;233(13):1362–1365. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES